Lingling Zhao Zhen Wang Haiwei Du Songan Chen Pingli Wang
10.3389/fonc.2021.605853
Front Oncol
2021 Apr 7;11:605853.
egfr-kdd afatinib lung adenocarcinoma next-generation sequencing tyrosine kinase inhibitor
CC BY
https://pubmed.ncbi.nlm.nih.gov/33898306/
Case Reports
PMC8059409
33898306
Lung Adenocarcinoma Patient Harboring EGFR-KDD Achieve Durable Response to Afatinib: A Case Report and Literature Review
2021